Skip to main content
. 2016 Mar 23;4(5):528–534. doi: 10.3892/br.2016.639

Table III.

Cell-penetrating peptide applications.

Study, year Application Examples Refs.
Ruan et al, 2007 Imaging Tat-QDs (55)
Lei et al, 2008 (56)
Prantner et al, 2003 Gd-DOTA-D-Tat (57)
Polyakov et al, 2000 Tat-(99m)Tc (58)
Deshayes et al, 2010 Anti-inflammation CPP-PNA (63)
Tan et al, 2005 (64)
Tilley et al, 2007 CPP-PMO (65)
Davé et al, 2007 CPP-NBD (71)
Peterson et al, 2011 Antp-NBD (72)
Koshkaryev et al, 2013 Tumor therapy R8-DOPE-BLM (76)
Walker et al, 2012 DOXO-ELP-CPP (77)
Aroui et al, 2010 Dox (78)
Dubikovskaya et al, 2008 Taxol (79)
Lindgren et al, 2006 Methotrexate (80)
Eguchi and Dowdy, 2009 Nucleic acid and Protein delivery CPP-siRNA (21)
Muratovska and Eccles, 2004 (82)
Favaro et al, 2014 T-Rp3 (83)
Eto et al, 2009 Viral delivery CPP-Adv (86)